Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Good Samaritan Hospital tops HealthGrade ratings for stroke treatment and joint replacement

A study issued today by HealthGrades, Inc., the leading independent healthcare ratings organization, finds that Good Samaritan Hospital is among the Top 5% in the Nation for Treatment of Stroke and Top 10% in the Nation for Joint Replacement. The nation’s nearly 5,000 nonfederal hospitals were all included in the sweeping study, which examined mortality rates and complication rates from government data from 2006, 2007 and 2008.

13 Oct 2009

North Bend Medical Centers partners with Oracle and PracticeOne to support its medical specialties

North Bend Medical Centers of Coos Bay, Oregon, a 55-physician, 300+ employee, multi-specialty clinic and provider to over 60,000 patients, is an innovative user of healthcare information technology. The clinic is comprised of five locations across southern Oregon and represents 15 medical specialties and has partnered closely with PracticeOne and Oracle as key technology providers to support its doctors and clinics.

13 Oct 2009

Debiopharm Group and Ipsen complete European decentralised registration of Decapeptyl

Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical Group, announced that the 6-month sustained-release formulation of Decapeptyl®1 (triptorelin embonate2 22.5 mg) successfully completed its European decentralised registration procedure involving nine countries: Germany (reference member state), France, Austria, Finland, Norway, Belgium, Denmark, Spain and The Netherlands.

13 Oct 2009

Phyton Biotech purchases NPI’s assets

Phyton Biotech, LLC (Phyton), an affiliate of Phyton, Inc., today announced that it has purchased the assets of Natural Pharmaceuticals, Inc. (NPI), a leading manufacturer of oncology drug active pharmaceutical ingredients (API’s).

13 Oct 2009

Spectrum Pharmaceuticals receives Complete Response letter from the FDA for FUSILEV

Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding its supplemental New Drug Application (sNDA) for FUSILEV (levoleucovorin) for injection for treatment of patients with advanced metastatic colorectal cancer.

13 Oct 2009

Ethicon Endo-Surgery launches energy delivery devices at the 95th ACS Annual Clinical Congress

Ethicon Endo-Surgery, Inc., today unveiled its broad portfolio of energy delivery devices at the 95th Annual Clinical Congress of the American College of Surgeons (ACS).

12 Oct 2009

WellPoint honored for its "Journey Forward" initiative

WellPoint, Inc. was recognized today as a 2009 BlueWorks® award winner. BlueWorks is a unique partnership between the Blue Cross and Blue Shield Association (BCBSA) and the Harvard Medical School Department of Health Care Policy that honors health care innovation that improves the quality and value of health care for consumers.

12 Oct 2009

Ethicon Endo-Surgery introduces the Echelon Flex Endopath Stapler at the 95th ACS Congress

Ethicon Endo-Surgery today announced the launch of the Echelon Flex(TM) Endopath® Stapler, which delivers system wide compression in a novel way through the first and only articulating mechanical endocutter designed to be fully operated with one hand.

12 Oct 2009

Ethicon Endo-Surgery introduces several novel surgical solutions at ACS Annual Clinical Congress

Ethicon Endo-Surgery introduced several novel surgical solutions at the 95th Annual Clinical Congress of the American College of Surgeons, highlighting how the company is enabling innovation through collaboration across the continuum of surgical techniques and options.

12 Oct 2009

Xoft to showcase a variety of investigational IORT oncology applications at ACS Annual Congress

Clinical experience with the FDA cleared Axxent® Electronic Brachytherapy, eBx(TM), System from Xoft shows promise for the multi-disciplinary use of the isotope-free cancer treatment platform to deliver intraoperative radiation therapy (IORT). Xoft will showcase a variety of investigational IORT oncology applications at the American College of Surgeons 95th Annual Clinical Congress here in Chicago, October 11-15, 2009.

12 Oct 2009

Synta Pharmaceuticals updates its Phase 3 SYMMETRY trial results at the Melanoma XIII Conference

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that additional results from its Phase 3 trial (SYMMETRYSM) of elesclomol in combination with paclitaxel in metastatic melanoma was presented at the Perspectives in Melanoma XIII Conference by Steven O’Day, M.D., principal investigator and Chief of Research and Director of the Melanoma Program at the Angeles Clinic in Santa Monica, California.

12 Oct 2009

TomoTherapy to present an update on TomoTherapy radiation therapy platform

TomoTherapy Incorporated announced today that it will host an analyst and investor presentation in conjunction with the annual ASTRO (American Society for Radiation Oncology) meeting on Monday, Nov. 2, 2009, at 8:00 a.m. CT.

12 Oct 2009

OptumHealth’s conference to focus on advancements in fetal diagnosis and treatment

OptumHealth Inc. has teamed with The Children’s Hospital of Philadelphia (CHOP) to present a two-day educational conference focused on clinical advancements in fetal diagnosis and treatment, neonatal care and pediatric care. The gathering runs through today, and is part of OptumHealth’s Network Spotlight Conferences program.

12 Oct 2009

Breast cancer patients who achieve pathological complete response have better outcomes

Locally advanced breast cancer patients who received the same class of neoadjuvant chemotherapy were found to have no evidence of disease at the time of their surgery, or achieved pathological complete response, at the same rate regardless of race, according to researchers at The University of Texas M. D. Anderson Cancer Center.

12 Oct 2009

Nektar Therapeutics presents the results from Phase 2 clinical trial of oral NKTR-118

Nektar Therapeutics presented topline data today from its Phase 2 clinical trial of oral NKTR-118 at the American Academy of Pain Management's (AAPM) 20th Annual Clinical Meeting in Phoenix, Arizona.

12 Oct 2009

Overview of procedures and techniques used for embryo transfer under transvaginal ultrasound guidance

Fertility and reproductive specialists are invited to join a live, online chat event entitled, “Transvaginal Ultrasound Transfers” at www.CookARTLab.com. The

12 Oct 2009

Federal stimulus funds for comparative-effectiveness research in cancer

Researchers at Fred Hutchinson Cancer Research Center, Group Health Research Institute and the University of Washington schools of Public Health and Pharmacy have been selected to lead four projects backed by approximately $16 million in federal stimulus funding for comparative-effectiveness research in cancer.

12 Oct 2009

Researchers find how KEAP1 tumor suppressor works

A tumor-suppressing protein snatches up an important cancer-promoting enzyme and tags it with molecules that condemn it to destruction, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports this week in the journal Molecular Cell.

12 Oct 2009

Socioeconomic and geographic disparities in the use of breast-conservating therapy

According to a new study published in the October issue of the Journal of the American College of Surgeons, although breast-conserving surgery (BCS), commonly known as lumpectomy, is increasingly being used to treat older women with nonmetastatic invasive breast cancer, there are still significant socioeconomic and geographic disparities in the use of this type of therapy.

12 Oct 2009

M. D. Anderson Cancer Center researchers announce study results of treatment for rare pediatric brain cancer

A team of researchers led by The University of Texas M. D. Anderson Cancer Center unveiled results today from the largest-ever collaborative study addressing the treatment of a rare pediatric brain tumor. The findings suggest a new standard protocol could improve survival nearly two-fold for pediatric patients with choroid plexus tumors, as reported at the 41st Annual Meeting of the International Society of Pediatric Oncology (SIOP).

12 Oct 2009

Oncology News and Research

Further Reading

Good Samaritan Hospital tops HealthGrade ratings for stroke treatment and joint replacement

North Bend Medical Centers partners with Oracle and PracticeOne to support its medical specialties

Debiopharm Group and Ipsen complete European decentralised registration of Decapeptyl

Phyton Biotech purchases NPI’s assets

Spectrum Pharmaceuticals receives Complete Response letter from the FDA for FUSILEV

Ethicon Endo-Surgery launches energy delivery devices at the 95th ACS Annual Clinical Congress

WellPoint honored for its "Journey Forward" initiative

Ethicon Endo-Surgery introduces the Echelon Flex Endopath Stapler at the 95th ACS Congress

Ethicon Endo-Surgery introduces several novel surgical solutions at ACS Annual Clinical Congress

Xoft to showcase a variety of investigational IORT oncology applications at ACS Annual Congress

Synta Pharmaceuticals updates its Phase 3 SYMMETRY trial results at the Melanoma XIII Conference

TomoTherapy to present an update on TomoTherapy radiation therapy platform

OptumHealth’s conference to focus on advancements in fetal diagnosis and treatment

Breast cancer patients who achieve pathological complete response have better outcomes

Nektar Therapeutics presents the results from Phase 2 clinical trial of oral NKTR-118

Overview of procedures and techniques used for embryo transfer under transvaginal ultrasound guidance

Federal stimulus funds for comparative-effectiveness research in cancer

Researchers find how KEAP1 tumor suppressor works

Socioeconomic and geographic disparities in the use of breast-conservating therapy

M. D. Anderson Cancer Center researchers announce study results of treatment for rare pediatric brain cancer

Cancer Research eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News